MedTrace Logo

How Reflux Medications Affect the Microbiome of Infants

NCT03747991 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 12

Last updated 2024-06-12

No results posted yet for this study

Summary

The changes in the organisms making up the gut microbiota in infants who are taking anti-acid reflux medications (histamine 2 receptor antagonists) as compared to infants who are not taking these medications is not well-studied or understood. Whether these medications change the gut microbiota and microbiome, and what that change may imply for children on these medications, is the focus of this study.

Conditions

Sponsors & Collaborators

  • Nemours Children's Clinic

    lead OTHER

Principal Investigators

  • Matthew Di Guglielmo, MD PhD · Nemours

Eligibility

Min Age
2 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2019-04-30
Completion
2019-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03747991 on ClinicalTrials.gov